German Oncological Data Standard (GOLD)
0.1.0 - CI Build Germany flag

German Oncological Data Standard (GOLD) - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

: Example Study NAPKON COVIDOM - XML Representation

Raw xml | Download



<ResearchStudy xmlns="http://hl7.org/fhir">
  <id value="ExampleStudyNapkonCovidom"/>
  <meta>
    <profile
             value="https://www.vision-zero-oncology.de/fhir/StructureDefinition/clinical-study"/>
  </meta>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: ResearchStudy</b><a name="ExampleStudyNapkonCovidom"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ResearchStudy &quot;ExampleStudyNapkonCovidom&quot; </p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-clinical-study.html">Profile Clinical Study</a></p></div><p><b>identifier</b>: id: NCT04679584, id: DRKS00023742</p><p><b>title</b>: COVIDOM: Longterm Morbidity of SARS-CoV-2 Infection and COVID-19 Disease - Consequences for Health Status and Quality of Life (NAPKON-POP)</p><p><b>status</b>: active</p><p><b>phase</b>: N/A <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-research-study-phase.html">ResearchStudyPhase</a>#n-a)</span></p><p><b>category</b>: Observational Study <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-nciThesaurus.html">NCI Thesaurus</a>#C16084)</span>, Cohort Study <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-nciThesaurus.html">NCI Thesaurus</a>#C15208)</span></p><p><b>condition</b>: Disease caused by severe acute respiratory syndrome coronavirus 2 (disorder) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#840539006)</span></p><p><b>contact</b>: Stefan Schreiber, Prof. Dr.: <a href="mailto:s.schreiber@mucosa.de">s.schreiber@mucosa.de</a>,ph: 0049 (0)431 500 22201, <a href="mailto:thomas.bahmer@uksh.de">thomas.bahmer@uksh.de</a>,ph: 0049 (0) 431 500 62629</p><p><b>location</b>: Germany <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-ISO3166Part1.html">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#DE)</span></p><p><b>period</b>: 2020-11-16 --&gt; 2021-12-31</p><p><b>sponsor</b>: <a href="https://simplifier.net/resolve?scope=de.basisprofil.r4@1.4.0&amp;canonical=http://fhir.org/packages/de.basisprofil.r4/Organization/UKSH">Organization/UKSH</a></p><p><b>principalInvestigator</b>: <a href="https://simplifier.net/resolve?scope=de.basisprofil.r4@1.4.0&amp;canonical=http://fhir.org/packages/de.basisprofil.r4/Practitioner/example">Practitioner/example</a></p><blockquote><p><b>objective</b></p><p><b>name</b>: Longterm morbidities and sequels of SARS-CoV-2 infections in the general population</p><p><b>type</b>: Primary <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-research-study-objective-type.html">ResearchStudyObjectiveType</a>#primary)</span></p></blockquote><blockquote><p><b>objective</b></p><p><b>name</b>: Longterm quality of life of SARS-CoV-2 infected individuals recruited from the general population</p><p><b>type</b>: Secondary <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-research-study-objective-type.html">ResearchStudyObjectiveType</a>#secondary)</span></p></blockquote></div>
  </text>
  <identifier>
    <system value="http://clinicaltrials.gov"/>
    <value value="NCT04679584"/>
  </identifier>
  <identifier>
    <system value="https://www.drks.de"/>
    <value value="DRKS00023742"/>
  </identifier>
  <title
         value="COVIDOM: Longterm Morbidity of SARS-CoV-2 Infection and COVID-19 Disease - Consequences for Health Status and Quality of Life (NAPKON-POP)"/>
  <status value="active"/>
  <phase>
    <coding>
      <system
              value="http://terminology.hl7.org/CodeSystem/research-study-phase"/>
      <code value="n-a"/>
    </coding>
  </phase>
  <category>
    <coding>
      <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl"/>
      <code value="C16084"/>
      <display value="Observational Study"/>
    </coding>
  </category>
  <category>
    <coding>
      <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl"/>
      <code value="C15208"/>
      <display value="Cohort Study"/>
    </coding>
  </category>
  <condition>
    <coding>
      <system value="http://snomed.info/sct"/>
      <code value="840539006"/>
      <display
               value="Disease caused by severe acute respiratory syndrome coronavirus 2 (disorder)"/>
    </coding>
  </condition>
  <contact>
    <name value="Stefan Schreiber, Prof. Dr."/>
    <telecom>
      <system value="email"/>
      <value value="s.schreiber@mucosa.de"/>
    </telecom>
    <telecom>
      <system value="phone"/>
      <value value="0049 (0)431 500 22201"/>
    </telecom>
  </contact>
  <contact>
    <telecom>
      <system value="email"/>
      <value value="thomas.bahmer@uksh.de"/>
    </telecom>
    <telecom>
      <system value="phone"/>
      <value value="0049 (0) 431 500 62629"/>
    </telecom>
  </contact>
  <location>
    <coding>
      <system value="urn:iso:std:iso:3166"/>
      <code value="DE"/>
      <display value="Germany"/>
    </coding>
  </location>
  <period>
    <start value="2020-11-16"/>
    <end value="2021-12-31"/>
  </period>
  <sponsor>
    <reference value="Organization/UKSH"/>
  </sponsor>
  <principalInvestigator>
    <reference value="Practitioner/example"/>
  </principalInvestigator>
  <objective>
    <name
          value="Longterm morbidities and sequels of SARS-CoV-2 infections in the general population"/>
    <type>
      <coding>
        <system
                value="http://terminology.hl7.org/CodeSystem/research-study-objective-type"/>
        <code value="primary"/>
      </coding>
    </type>
  </objective>
  <objective>
    <name
          value="Longterm quality of life of SARS-CoV-2 infected individuals recruited from the general population"/>
    <type>
      <coding>
        <system
                value="http://terminology.hl7.org/CodeSystem/research-study-objective-type"/>
        <code value="secondary"/>
      </coding>
    </type>
  </objective>
</ResearchStudy>